Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
Johns Hopkins Kimmel Cancer Center in Baltimore
All US Allogeneic Transplant Donors and Recipients weighing 20 or more kg may participate in this collection of samples.
The goal of this study is to establish a cohort of biologic samples collected prospectively from patients treated in BMT CTN centers that will be a shared biospecimen resource for conducting future allogeneic hematopoietic stem cell transplantation (HCT) correlative studies.
05/25/2016 05:03 AM